CBD News is Frequently a Topic of Choice – Here’s the Best of the Best
Over the course of the first 100 episodes of The Hoban Minute, Bob and Eric have spoken with leaders of the CBD and cannabinoid industry in the U.S. and around the world. These conversations have touched on every part of the CBD supply chain, from cultivation to manufacturing to the law, policy, and regulations shaping the global CBD industry. Here are a few of the best Hoban Minute episodes on CBD:
Could CBD Cure Coronavirus? The Do’s and Don’ts of Claims and Representations
Bob and Eric explore the cutting-edge of research on cannabinoids, flavonoids, and terpenes derived from industrial hemp and medical cannabis with founder and CEO of iCAN and Organizer of CannaTech, Saul Kaye.
Breaking Update on FDA Letters to CBD Companies Making COVID Claims
Bob and Eric discuss letters from the U.S. Food and Drug Administration to CBD companies who have made claims that cannabinoids could boost immunity to COVID-19 with Texas-based Hoban Law Group attorney, Ashley Simpson.
The Next CBD: What’s on the Horizon for Minor Cannabinoids, Terpenes, and Flavonoids
Bob and Eric consider the market potential for minor cannabinoids like cannabigerol (CBG) and cannabinol (CBN) and the legal and regulatory differences between synthetic-derived and plant-derived cannabinoids with host of the Hemp Barons podcast, Joy Beckerman.
The Need for Standards in Legitimizing Cannabis
Ceci and Eric examine the work of the International Cannabis and Cannabinoids Institute (ICCI), the creation of cannabis industry standards, and the challenges facing the legitimization and large enterprise involvement in the cannabinoid sector with President of the (ICCI) and founder of Americans for Safe Access, Steph Sherer.
The Endocannabinoid System
Bob and Eric investigate the medicinal value of cannabinoids, the complex workings of the endocannabinoid system, and barriers to CBD research with holistic practitioner, educator, and CEO of Monaco Natural Health, Dr. Carlie Bell-Biggins.